|
CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and …
MarketWatch VIENNA, Va., Oct 21, 2014 (BUSINESS WIRE) — CEL-SCI Corporation (nyse mkt:CVM), a late-stage oncology company, today announced that it has priced a “best efforts” underwritten public offering of common stock and warrants at a combined price of $0.76 … CEL-SCI Corporation to Raise $1 Million in Registered Direct OfferingBusiness Wire (press release) |
